SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001140361-23-017337
Filing Date
2023-04-07
Accepted
2023-04-07 16:16:24
Documents
12
Period of Report
2023-04-04
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 FORM 8-K ny20006478x2_8k.htm   iXBRL 8-K 30715
  Complete submission text file 0001140361-23-017337.txt   170435

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA cbio-20230404.xsd EX-101.SCH 3907
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE cbio-20230404_lab.xml EX-101.LAB 22546
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cbio-20230404_pre.xml EX-101.PRE 16072
6 EXTRACTED XBRL INSTANCE DOCUMENT ny20006478x2_8k_htm.xml XML 4211
Mailing Address 611 GATEWAY BLVD., SUITE 710 SOUTH SAN FRANCISCO CA 94080
Business Address 611 GATEWAY BLVD., SUITE 710 SOUTH SAN FRANCISCO CA 94080 650-871-0761
CATALYST BIOSCIENCES, INC. (Filer) CIK: 0001124105 (see all company filings)

IRS No.: 562020050 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-51173 | Film No.: 23808920
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences